Liabilities / Assets
Score unavailable
Liabilities-to-assets requires both liabilities and assets on this filing.
990EZ • Fiscal year 2024 • EIN 82-4257211
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
Score unavailable
Liabilities-to-assets requires both liabilities and assets on this filing.
Liabilities / Revenue
Score unavailable
Liabilities-to-revenue requires both liabilities and revenue on this filing.
Net Margin
19th percentile
Higher net margin than 19% of similar nonprofits.
Top Officer Pay
86th percentile
Higher top officer pay than 86% of similar nonprofits.
Top officer pay equals 26.2% of source-year revenue.
Asset Growth
4th percentile
Faster asset growth than 4% of similar nonprofits.
Revenue Growth
40th percentile
Faster revenue growth than 40% of similar nonprofits.
Assets
Down$1,074
Down $15,880 (-94%) from 2023
Net Assets
Down$1,074
Down $15,880 (-94%) from 2023
Liabilities
-
No earlier filing loaded for comparison.
Revenue
Down$80,250
Down $3,822 (-4.5%) from 2023
Expenses
Up$96,130
Up $24,477 (+34%) from 2023
Net Income
Down-$15,880
Down $28,299 (-228%) from 2023
The isthmus foundation (tif) is a non-profit organization dedicated to transforming stem cell discoveries into cures for unmet medical needs. Through our alliances we bridge the gap between academic and scientific research and the development and delivery of more effective patient therapies. Our advocacy and passion leverage regional and global resources, partnerships, and funds to advance promising stem cell science for human health. Stem cells are powerful because of their versatility. The ability to differentiate into other cell types, to repair and modify injured and diseased tissue and be manufactured and delivered as clinical products holds the promise for developing new treatments and cures for a wide range of conditions such as cancer, diabetes, heart disease & neurological.
| Description | Grants | Expenses |
|---|---|---|
| THE ISTHMUS FOUNDATIONS APPROACH TO ACCELERATING THE TRANSLATION OF STEM CELL THERAPIES IS HIGHLY COLLABORATIVE, INVOLVING AN EVER-EXPANDING NETWORK OF SCIENTISTS, CLINICIANS, INVESTORS, BUSINESSES, HEALTHCARE PROVIDERS, AND MANUFACTURING EXPERTS THAT HAVE THE COLLECTIVE RESOURCES TO TRANSLATE STEM CELL ADVANCEMENTS INTO THERAPIES AND PRODUCTS. THESE RELATIONSHIPS ALLOW ISTHMUS TO DEVELOP AND MATURE THE VALUE OF EMERGING STEM CELL TECHNOLOGIES TO LAUNCH THE NEXT WAVE OF COMPANIES THAT WILL CHANGE THE LIVES OF PATIENTS AND THEIR FAMILIES, WORLDWIDE. WE ADVANCE SUPPORTED CANDIDATE RESEARCH THROUGH THE APPLICATION OF WORLD CLASS PROJECT MANAGEMENT AND STRATEGIC BUSINESS DEVELOPMENT IN THREE STAGES: 1. IDENTIFY 2. INNOVATE 3. IMPLEMENT | - | $82,941 |
| Name | Title | Full / Part Time | Base | Other | Total |
|---|---|---|---|---|---|
| ROSS DUNBAR | Executive Di | PT | $21,000 | - | $21,000 |
| JAMES DUTTON | Vice Chair | - | $0 | - | - |
| MICHAEL OKERLUND | Secretary | - | $0 | - | - |
| STEVE WOLD | Retired VP/C | - | $0 | - | - |
“Expenses travel 97 meals 473 sub contractors 26,202 materials/engineering 28,449 mn attorney general 25 bank fees 8 registration fees 155 market research 225 donation 5,000 total 60,634”
“The isthmus foundation (tif) is a non-profit organization dedicated to transforming stem cell discoveries into cures for unmet medical needs. Through our alliances we bridge the gap between academic and scientific research and the development and delivery of more effective patient therapies. Our advocacy and passion leverage regional and global resources, partnerships, and funds to advance promising stem cell science for human health. Stem cells are powerful because of their versatility. The ability to differentiate into other cell types, to repair and modify injured and diseased tissue and be manufactured and delivered as clinical products holds the promise for developing new treatments and cures for a wide range of conditions such as cancer, diabetes, heart disease & neurological.”
“The isthmus foundations approach to accelerating the translation of stem cell therapies is highly collaborative, involving an ever-expanding network of scientists, clinicians, investors, businesses, healthcare providers, and manufacturing experts that have the collective resources to translate stem cell advancements into therapies and products. These relationships allow isthmus to develop and mature the value of emerging stem cell technologies to launch the next wave of companies that will change the lives of patients and their families, worldwide. We advance supported candidate research through the application of world class project management and strategic business development in three stages: 1. Identify 2. Innovate 3. Implement”
This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.
| Path | # | Value |
|---|---|---|
| IRS990EZ/ActivitiesNotPreviouslyRptInd | 0 | false |
| IRS990EZ/BooksInCareOfDetail/PersonNm | 0 | ROSS DUNBAR |
| IRS990EZ/BooksInCareOfDetail/PhoneNum | 0 | 9523007176 |
| IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt | 0 | 10141 IRWIN RD |
| IRS990EZ/BooksInCareOfDetail/USAddress/CityNm | 0 | MINNEAPOLIS |
| IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd | 0 | MN |
| IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd | 0 | 55437 |
| IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt | 0 | 16954 |
| IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt | 0 | 1074 |
| IRS990EZ/ChgMadeToOrgnzngDocNotRptInd | 0 | false |
| IRS990EZ/ContributionsGiftsGrantsEtcAmt | 0 | 80250 |
| IRS990EZ/DonorAdvisedFndsInd | 0 | false |
| IRS990EZ/EngagedInExcessBenefitTransInd | 0 | false |
| IRS990EZ/ExcessOrDeficitForYearAmt | 0 | -15880 |
| IRS990EZ/FeesAndOtherPymtToIndCntrctAmt | 0 | 14496 |
| IRS990EZ/FiledScheduleAInd | 0 | true |
| IRS990EZ/ForeignFinancialAccountInd | 0 | false |
| IRS990EZ/ForeignOfficeInd | 0 | false |
| IRS990EZ/Form1120PolFiledInd | 0 | false |
| IRS990EZ/Form990TotalAssetsGrp/BOYAmt | 0 | 16954 |
| IRS990EZ/Form990TotalAssetsGrp/EOYAmt | 0 | 1074 |
| IRS990EZ/GrossReceiptsAmt | 0 | 80250 |
| IRS990EZ/InfoInScheduleOPartIIIInd | 0 | X |
| IRS990EZ/InfoInScheduleOPartIInd | 0 | X |
| IRS990EZ/LobbyingActivitiesInd | 0 | false |
| IRS990EZ/MadeLoansToFromOfficersInd | 0 | false |
| IRS990EZ/MethodOfAccountingCashInd | 0 | X |
| IRS990EZ/NetAssetsOrFundBalancesBOYAmt | 0 | 16954 |
| IRS990EZ/NetAssetsOrFundBalancesEOYAmt | 0 | 1074 |
| IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt | 0 | 16954 |
| IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt | 0 | 1074 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 0 | 12.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 1 | 3.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 2 | 0.50 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 3 | 0.50 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 0 | 21000 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 1 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 2 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 3 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 0 | ROSS DUNBAR |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 1 | JAMES DUTTON |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 2 | MICHAEL OKERLUND |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 3 | STEVE WOLD |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 0 | EXECUTIVE DI |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 1 | VICE CHAIR |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 2 | SECRETARY |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 3 | RETIRED VP/C |
| IRS990EZ/OperateHospitalInd | 0 | false |
| IRS990EZ/Organization501c3Ind | 0 | X |
| IRS990EZ/OrganizationDissolvedEtcInd | 0 | false |
| IRS990EZ/OrganizationHadUBIInd | 0 | false |
| IRS990EZ/OtherExpensesTotalAmt | 0 | 60634 |
| IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt | 0 | NONE |
| IRS990EZ/PartVIOfCompOfHghstPdEmplTxt | 0 | NONE |
| IRS990EZ/PoliticalCampaignActyInd | 0 | false |
| IRS990EZ/PrimaryExemptPurposeTxt | 0 | THE ISTHMUS FOUNDATION (TIF) IS A NON-PROFIT ORGANIZATION DEDICATED TO TRANSFORMING STEM CELL DISCOVERIES INTO CURES FOR UNMET MEDICAL NEEDS. THROUGH OUR ALLIANCES WE BRIDGE THE GAP BETWEEN ACADEMIC AND SCIENTIFIC RESEARCH AND THE DEVELOPMENT AND DELIVERY OF MORE EFFECTIVE PATIENT THERAPIES. OUR ADVOCACY AND PASSION LEVERAGE REGIONAL AND GLOBAL RESOURCES, PARTNERSHIPS, AND FUNDS TO ADVANCE PROMISING STEM CELL SCIENCE FOR HUMAN HEALTH. STEM CELLS ARE POWERFUL BECAUSE OF THEIR VERSATILITY. THE ABILITY TO DIFFERENTIATE INTO OTHER CELL TYPES, TO REPAIR AND MODIFY INJURED AND DISEASED TISSUE AND BE MANUFACTURED AND DELIVERED AS CLINICAL PRODUCTS HOLDS THE PROMISE FOR DEVELOPING NEW TREATMENTS AND CURES FOR A WIDE RANGE OF CONDITIONS SUCH AS CANCER, DIABETES, HEART DISEASE & NEUROLOGICAL. |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt | 0 | THE ISTHMUS FOUNDATIONS APPROACH TO ACCELERATING THE TRANSLATION OF STEM CELL THERAPIES IS HIGHLY COLLABORATIVE, INVOLVING AN EVER-EXPANDING NETWORK OF SCIENTISTS, CLINICIANS, INVESTORS, BUSINESSES, HEALTHCARE PROVIDERS, AND MANUFACTURING EXPERTS THAT HAVE THE COLLECTIVE RESOURCES TO TRANSLATE STEM CELL ADVANCEMENTS INTO THERAPIES AND PRODUCTS. THESE RELATIONSHIPS ALLOW ISTHMUS TO DEVELOP AND MATURE THE VALUE OF EMERGING STEM CELL TECHNOLOGIES TO LAUNCH THE NEXT WAVE OF COMPANIES THAT WILL CHANGE THE LIVES OF PATIENTS AND THEIR FAMILIES, WORLDWIDE. WE ADVANCE SUPPORTED CANDIDATE RESEARCH THROUGH THE APPLICATION OF WORLD CLASS PROJECT MANAGEMENT AND STRATEGIC BUSINESS DEVELOPMENT IN THREE STAGES: 1. IDENTIFY 2. INNOVATE 3. IMPLEMENT |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt | 0 | 82941 |
| IRS990EZ/ProhibitedTaxShelterTransInd | 0 | false |
| IRS990EZ/RelatedOrganizationCtrlEntInd | 0 | false |
| IRS990EZ/SalariesOtherCompEmplBnftAmt | 0 | 21000 |
| IRS990EZ/SchoolOperatingInd | 0 | false |
| IRS990EZ/StatesWhereCopyOfReturnIsFldCd | 0 | MN |
| IRS990EZ/SubjectToProxyTaxInd | 0 | false |
| IRS990EZ/TanningServicesProvidedInd | 0 | false |
| IRS990EZ/TotalExpensesAmt | 0 | 96130 |
| IRS990EZ/TotalProgramServiceExpensesAmt | 0 | 82941 |
| IRS990EZ/TotalRevenueAmt | 0 | 80250 |
| IRS990EZ/TransactionWithControlEntInd | 0 | false |
| IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd | 0 | false |
| IRS990EZ/TypeOfOrganizationCorpInd | 0 | X |
| IRS990EZ/WebsiteAddressTxt | 0 | WWW.ISTHMUSFOUNDATION.ORG |
| IRS990ScheduleA/AmountsRcvdDsqlfyPersonGrp/CurrentTaxYearAmt | 0 | 5000 |
| IRS990ScheduleA/AmountsRcvdDsqlfyPersonGrp/CurrentTaxYearMinus1YearAmt | 0 | 322 |
| IRS990ScheduleA/AmountsRcvdDsqlfyPersonGrp/CurrentTaxYearMinus2YearsAmt | 0 | 5582 |
| IRS990ScheduleA/AmountsRcvdDsqlfyPersonGrp/TotalAmt | 0 | 10904 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt | 0 | 80250 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt | 0 | 84072 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt | 0 | 23331 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt | 0 | 32030 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus4YearsAmt | 0 | 18000 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt | 0 | 237683 |
| IRS990ScheduleA/InvestmentIncomeCYPct | 0 | 0.00000 |
| IRS990ScheduleA/InvestmentIncomePYPct | 0 | 0.00000 |
| IRS990ScheduleA/PubliclySupportedOrg509a2Ind | 0 | X |
| IRS990ScheduleA/PublicSupportCY509Pct | 0 | 0.95410 |
| IRS990ScheduleA/PublicSupportPY509Pct | 0 | 1.00000 |
| IRS990ScheduleA/PublicSupportTotal509Amt | 0 | 226779 |
| IRS990ScheduleA/SubstAndDsqlfyPrsnsTotGrp/CurrentTaxYearAmt | 0 | 5000 |
| IRS990ScheduleA/SubstAndDsqlfyPrsnsTotGrp/CurrentTaxYearMinus1YearAmt | 0 | 322 |
| IRS990ScheduleA/SubstAndDsqlfyPrsnsTotGrp/CurrentTaxYearMinus2YearsAmt | 0 | 5582 |
| IRS990ScheduleA/SubstAndDsqlfyPrsnsTotGrp/TotalAmt | 0 | 10904 |
| IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind | 0 | X |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt | 0 | 80250 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt | 0 | 84072 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt | 0 | 23331 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt | 0 | 32030 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt | 0 | 18000 |
| IRS990ScheduleA/Total509Grp/TotalAmt | 0 | 237683 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt | 0 | 80250 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt | 0 | 84072 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt | 0 | 23331 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt | 0 | 32030 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt | 0 | 18000 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt | 0 | 237683 |
| IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine1 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorNum | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine1 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine2 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt | 0 | RESTRICTED |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 0 | EXPENSES TRAVEL 97 MEALS 473 SUB CONTRACTORS 26,202 MATERIALS/ENGINEERING 28,449 MN ATTORNEY GENERAL 25 BANK FEES 8 REGISTRATION FEES 155 MARKET RESEARCH 225 DONATION 5,000 TOTAL 60,634 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 1 | THE ISTHMUS FOUNDATION (TIF) IS A NON-PROFIT ORGANIZATION DEDICATED TO TRANSFORMING STEM CELL DISCOVERIES INTO CURES FOR UNMET MEDICAL NEEDS. THROUGH OUR ALLIANCES WE BRIDGE THE GAP BETWEEN ACADEMIC AND SCIENTIFIC RESEARCH AND THE DEVELOPMENT AND DELIVERY OF MORE EFFECTIVE PATIENT THERAPIES. OUR ADVOCACY AND PASSION LEVERAGE REGIONAL AND GLOBAL RESOURCES, PARTNERSHIPS, AND FUNDS TO ADVANCE PROMISING STEM CELL SCIENCE FOR HUMAN HEALTH. STEM CELLS ARE POWERFUL BECAUSE OF THEIR VERSATILITY. THE ABILITY TO DIFFERENTIATE INTO OTHER CELL TYPES, TO REPAIR AND MODIFY INJURED AND DISEASED TISSUE AND BE MANUFACTURED AND DELIVERED AS CLINICAL PRODUCTS HOLDS THE PROMISE FOR DEVELOPING NEW TREATMENTS AND CURES FOR A WIDE RANGE OF CONDITIONS SUCH AS CANCER, DIABETES, HEART DISEASE & NEUROLOGICAL. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 2 | THE ISTHMUS FOUNDATIONS APPROACH TO ACCELERATING THE TRANSLATION OF STEM CELL THERAPIES IS HIGHLY COLLABORATIVE, INVOLVING AN EVER-EXPANDING NETWORK OF SCIENTISTS, CLINICIANS, INVESTORS, BUSINESSES, HEALTHCARE PROVIDERS, AND MANUFACTURING EXPERTS THAT HAVE THE COLLECTIVE RESOURCES TO TRANSLATE STEM CELL ADVANCEMENTS INTO THERAPIES AND PRODUCTS. THESE RELATIONSHIPS ALLOW ISTHMUS TO DEVELOP AND MATURE THE VALUE OF EMERGING STEM CELL TECHNOLOGIES TO LAUNCH THE NEXT WAVE OF COMPANIES THAT WILL CHANGE THE LIVES OF PATIENTS AND THEIR FAMILIES, WORLDWIDE. WE ADVANCE SUPPORTED CANDIDATE RESEARCH THROUGH THE APPLICATION OF WORLD CLASS PROJECT MANAGEMENT AND STRATEGIC BUSINESS DEVELOPMENT IN THREE STAGES: 1. IDENTIFY 2. INNOVATE 3. IMPLEMENT |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 0 | FORM 990-EZ, PART I, LINE 16 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 1 | FORM 990-EZ, PART III |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 2 | FORM 990-EZ, PART III, LINE 28 |
| ReturnHeader/BuildTS | 0 | 2023-04-26 12:10:37Z |
| ReturnHeader/BusinessOfficerGrp/PersonNm | 0 | ROSS DUNBAR |
| ReturnHeader/BusinessOfficerGrp/PersonTitleTxt | 0 | EXECUTIVE DIRECTOR |
| ReturnHeader/BusinessOfficerGrp/PhoneNum | 0 | 9523007176 |
| ReturnHeader/BusinessOfficerGrp/SignatureDt | 0 | 2024-02-17 |
| ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt | 0 | THE ISTHMUS FOUNDATION |
| ReturnHeader/Filer/BusinessNameControlTxt | 0 | ISTH |
| ReturnHeader/Filer/EIN | 0 | 824257211 |
| ReturnHeader/Filer/PhoneNum | 0 | 9523007176 |
| ReturnHeader/Filer/USAddress/AddressLine1Txt | 0 | 10141 IRWIN RD |
| ReturnHeader/Filer/USAddress/CityNm | 0 | MINNEAPOLIS |
| ReturnHeader/Filer/USAddress/StateAbbreviationCd | 0 | MN |
| ReturnHeader/Filer/USAddress/ZIPCd | 0 | 55437 |
| ReturnHeader/IRSResponsiblePrtyInfoCurrInd | 0 | false |
| ReturnHeader/PreparerFirmGrp/PreparerFirmEIN | 0 | 410941592 |
| ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt | 0 | MAIR & ASSOCIATES PLLP |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt | 0 | 3570 LEXINGTON AVE N STE 300 |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm | 0 | SAINT PAUL |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd | 0 | MN |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd | 0 | 55126 |
| ReturnHeader/PreparerPersonGrp/PhoneNum | 0 | 6514821698 |
| ReturnHeader/PreparerPersonGrp/PreparationDt | 0 | 2024-02-26 |
| ReturnHeader/PreparerPersonGrp/PreparerPersonNm | 0 | BRUCE S MAIR |
| ReturnHeader/ReturnTs | 0 | 2024-02-26T12:37:48-05:00 |
| ReturnHeader/ReturnTypeCd | 0 | 990EZ |
| ReturnHeader/SigningOfficerGrp/PersonFullName/PersonFirstNm | 0 | ROSS |
| ReturnHeader/SigningOfficerGrp/PersonFullName/PersonLastNm | 0 | DUNBAR |
| ReturnHeader/TaxPeriodBeginDt | 0 | 2023-02-01 |
| ReturnHeader/TaxPeriodEndDt | 0 | 2024-01-31 |
| ReturnHeader/TaxYr | 0 | 2023 |
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2024 • Form 990EZDetailed filing. Detailed filing data is available for this year.